FDA finds 17 hospitals failed medical device reporting standards

The FDA had held regulatory meetings with multiple hospitals that have had differences from the Medical Device Reporting Regulation (21 CFR Part 803) and not given responses. The list includes 17 total hospitals that have failed to meet FDA standards in regard to the FDA 843 form.

(The FDA Form 483 notifies the company’s management of objectionable conditions. At the conclusion of an inspection, the the form is presented and discussed with the company’s senior management.)

The table of hospitals complied by the FDA show many problems within the facilities. Hospitals on the list include:

  • Cedars-Sinai Medical Center, Los Angeles
  • New York Presbyterian Hospital, New York
  • Indiana University Hospital, Indianapolis

Read the full report by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.